Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

By In The News
March 23, 2019 in The Headlines

Recommended Posts

In The News

Posted March 23, 2019

- Share

Posted March 23, 2019

NEW ORLEANS, March 23, 2019 /PRNewswire/ -- Oral semaglutide 7 mg and 14 mg demonstrated superior A1C and body weight reductions compared to Januvia® (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for A1C reduction at 26 weeks was not confirmed. Presented today at the...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220081
2. Jaydee
  16881
3. Kip Powick
  12240
4. deicer
  12240
5. dagger
  9596
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.4k
- Total Posts
  
  559.3k

Sign In

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support